Previous close | 0.9150 |
Open | 0.9250 |
Bid | 0.8600 x N/A |
Ask | 0.0000 x N/A |
Day's range | 0.9200 - 0.9700 |
52-week range | 0.6750 - 1.9050 |
Volume | |
Avg. volume | 117,287 |
Market cap | N/A |
Beta (5Y monthly) | 0.74 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Trajan Scientific and Medical, a leading provider of analytical and life sciences products and solutions, today announced the regulatory approval of its Neoteryx remote blood microsampling devices, Mitra® and hemaPEN® for clinical use in Europe and the United Kingdom.